Skip to main content

Want a detailed portfolio tracker?

BioRestorative Therapies (BRTX) P/E (2013 - 2026)

BioRestorative Therapies (BRTX) P/E from May 14, 2013 to Jul 20, 2026. The TTM BioRestorative Therapies (BRTX) P/E is -3.82. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioRestorative Therapies (BRTX)

YearP/EChange
2026-3.82+17.44%
2025-3.25-46.15%
2024-6.03-454.40%
20231.70-179.12%
2022-2.15+187.32%
2021-0.75-81.80%
2020-4.11+47.12%
2019-2.80-99.44%
2018-503.39-75.68%
2017-2.07K+12.12%
2016-1.85K-22.35%
2015-2.38K-52.78%
2014-5.03K-10.89%
2013-5.65KN/A

Comparison BioRestorative Therapies (BRTX) P/E with competitors

BioRestorative Therapies (BRTX) P/E is -3.82.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.96%
FGENFibroGen Inc0.24-106.29%
CHRSCoherus Biosciences Inc0.85-122.24%
FBIOFortress Biotech Inc0.95-124.87%
ORMPOramed Pharmaceuticals Inc1.50-139.39%
AGENAgenus Inc3.01-178.87%
INVAInnoviva Inc3.15-182.65%
VXRTVaxart Inc3.55-193.02%
CRMDCorMedix Inc3.63-195.09%
CVACCureVac N.V.4.45-216.50%
GLPGGalapagos NV4.86-227.33%
SRPTSarepta Therapeutics Inc4.88-227.94%
ABEOAbeona Therapeutics Inc5.39-241.18%
ABUSArbutus Biopharma Corp5.60-246.64%
ZVRAZevra Therapeutics Inc5.89-254.28%
SPROSpero Therapeutics Inc6.23-263.22%
CGENCompugen Ltd6.31-265.46%
RIGLRigel Pharmaceuticals6.87-280.09%
SLXNSilexion Therapeutics Corp7.30-291.20%
OMEROmeros Corporation9.26-342.63%
AUPHAurinia Pharmaceuticals Inc9.58-351.18%
PLXProtalix BioTherapeutics Inc10.89-385.41%
ACADAcadia Pharmaceuticals Inc11.73-407.36%
TBPHTheravance Biopharma Inc12.26-421.34%
ADMAAdma Biologics Inc12.42-425.43%
HRMYHarmony Biosciences Holdings Inc13.82-462.17%
SABSSAB Biotherapeutics Inc14.14-470.45%
NAGENiagen Bioscience Inc14.82-488.32%
INCYIncyte Corp15.82-514.64%
REGNRegeneron Pharmaceuticals Inc15.86-515.54%
PBYIPuma Biotechnology Inc17.32-553.77%
CPRXCatalyst Pharmaceuticals Inc17.44-557.01%
EXELExelixis Inc17.54-559.60%
TGTXTG Therapeutics Inc18.97-597.02%
MDXGMimedx Group Inc20.55-638.60%
XOMAXOMA Royalty Corp22.87-699.47%
ARGXArgen X SE24.30-736.77%
CTMXCytomX Therapeutics Inc24.82-750.48%
XOMAOXOMA Royalty Corp25.34-764.20%
HALOHalozyme Therapeutics Inc25.62-771.51%
XOMAPXOMA Royalty Corp25.67-772.73%
VRTXVertex Pharmaceuticals Inc27.99-833.65%
RPRXRoyalty Pharma plc - Class A28.69-851.80%
SLNOSoleno Therapeutics Inc29.02-860.39%
ASNDAscendis Pharma A/S30.09-888.44%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1093.55%
APLSApellis Pharmaceuticals Inc39.02-1122.61%
BMRNBiomarin Pharmaceutical Inc42.21-1206.23%
KRYSKrystal Biotech Inc45.34-1288.30%
ONCBeiGene Ltd69.54-1922.42%
PHARPharming Group N.V.75.03-2066.17%
TECHBio-Techne Corp101.96-2771.98%
VCELVericel Corp109.92-2980.67%
ALNYAlnylam Pharmaceuticals Inc117.96-3191.47%
GMABGenmab140.29-3776.55%
TLXTelix Pharmaceuticals Ltd162.15-4349.48%
CORTCorcept Therapeutics Inc212.86-5678.28%